Cargando…

Preoperative Changes in Hematological Markers and Predictors of Glioma Grade and Survival

Background: Preoperative hematological markers that indicate nutritional, coagulation, and inflammation statuses have prognostic value for gliomas. This study aimed to investigate hematological markers with regard to tumor grades, isocitrate dehydrogenase mutations (IDH), age, and sex in patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Peng-Fei, Meng, Zhe, Song, Hong-Wang, Yao, Kun, Duan, Ze-Jun, Yu, Chun-Jiang, Li, Shou-Wei, Yan, Chang-Xiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6103192/ https://www.ncbi.nlm.nih.gov/pubmed/30154718 http://dx.doi.org/10.3389/fphar.2018.00886

Ejemplares similares

Prognostic value of preoperative hematological markers combined with molecular pathology in patients with diffuse gliomas
por: Zhang, Zhen-Yu, et al.
Publicado: (2019)

Correlation between preoperative inflammatory markers, Ki-67 and the pathological grade of glioma
por: Xu, Guangda, et al.
Publicado: (2021)

Preoperative inflammation markers and IDH mutation status predict glioblastoma patient survival
por: Wang, Peng-Fei, et al.
Publicado: (2017)

Sanbo Scoring System, Based on Age and Pre-treatment Hematological Markers, is a Non-invasive and Independent Prognostic Predictor for Patients with Primary Glioblastomas: A Retrospective Multicenter Study
por: Wang, Peng-fei, et al.
Publicado: (2019)

Midkine expression in high grade gliomas: Correlation of this novel marker with proliferation and survival in human gliomas
por: Cheng, Yen-Po, et al.
Publicado: (2014)

Prognostic value of preoperative hematological markers in patients with glioblastoma multiforme and construction of random survival forest model
por: Duan, Xiaozong, et al.
Publicado: (2023)

Rechallenge to Carboplatin in Children with Low Grade Glioma and Carboplatin Hypersensitivity Reactions
por: Ruggiero, Antonio, et al.
Publicado: (2017)

Higher Plasma Fibrinogen Levels are Associated with Malignant Phenotype and Worse Survival in Patients with Glioblastomas
por: Wang, Peng-Fei, et al.
Publicado: (2018)

Comprehensive Analysis of Inflammatory Response–Related Genes, and Prognosis and Immune Infiltration in Patients With Low-Grade Glioma
por: Han, Tao, et al.
Publicado: (2021)

URB2 as an important marker for glioma prognosis and immunotherapy
por: Fang, Chaoyou, et al.
Publicado: (2023)

PROX1 is a predictor of survival for gliomas WHO grade II
por: Elsir, T, et al.
Publicado: (2011)

Use of Preoperative Ependymal Enhancement on Magnetic Resonance Imaging Brain as a Marker of Grade of Glioma
por: Sharma, Sumit, et al.
Publicado: (2017)

Clinical utility of arterial spin labeling for preoperative grading of glioma
por: Fu, Jun, et al.
Publicado: (2018)

Anlotinib Alone or in Combination With Temozolomide in the Treatment of Recurrent High-Grade Glioma: A Retrospective Analysis
por: Yang, Qunying, et al.
Publicado: (2021)

Factors Involved in Preoperative Edema in High-Grade Gliomas
por: Saito, Takashi, et al.
Publicado: (2022)

Efficacy and safety of pharmacotherapy for recurrent high-grade glioma: a systematic review and network meta-analysis
por: Xu, Yanan, et al.
Publicado: (2023)

Applying single cell multi-omic analyses to understand treatment resistance in pediatric high grade glioma
por: Murdaugh, Rebecca L., et al.
Publicado: (2023)

Contrahemispheric Cortex Predicts Survival and Molecular Markers in Patients With Unilateral High-Grade Gliomas
por: Yuan, Taoyang, et al.
Publicado: (2020)

Low GAS5 Levels as a Predictor of Poor Survival in Patients with Lower-Grade Gliomas
por: Wang, Yanfang, et al.
Publicado: (2019)

Preoperative systemic inflammatory markers in low- and high-grade gliomas: A retrospective analysis of 171 patients
por: Kemerdere, Rahsan, et al.
Publicado: (2019)

Development and Validation of a Nomogram Model Based on Hematological Indicators for Predicting the Prognosis of Diffused Gliomas
por: Han, Song, et al.
Publicado: (2022)

Survival benefit of preoperative hepatic arterial infusion of oxaliplatin, fluorouracil, and leucovorin followed by hepatectomy for hepatocellular carcinoma
por: Hu, Zili, et al.
Publicado: (2023)

Deciphering the Relationship Between the Trough Concentration of Posaconazole and Its Efficacy and Safety in Chinese Patients With Hematological Disorders
por: Jia, Meng-Meng, et al.
Publicado: (2020)

Clinical predictors for survival and treatment outcome of high-grade glioma in Prasat Neurological Institute
por: Noiphithak, Raywat, et al.
Publicado: (2017)

The Clinical Frailty Scale as predictor of overall survival after resection of high-grade glioma
por: Klingenschmid, Julia, et al.
Publicado: (2022)

PREOPERATIVE DETERMINATION OF IDH STATUS AND GRADE IN GLIOMAS USING MRS
por: Nguyen, Thanh Binh
Publicado: (2023)

Preoperative Patient-Reported Outcomes in Suspected Low-Grade Glioma: Markers of Disease Severity and Correlations with Molecular Subtypes
por: Buvarp, Dongni, et al.
Publicado: (2021)

Purine metabolism-related gene expression signature predicts survival outcome and indicates immune microenvironment profile of gliomas
por: Chen, Siliang, et al.
Publicado: (2022)

Prognostic values of preoperative albumin to globulin ratio for predicting clinical outcome in patients with high-grade gliomas
por: Liu, Jun, et al.
Publicado: (2019)

Research Progress About Glioma Stem Cells in the Immune Microenvironment of Glioma
por: Li, Xiangyu, et al.
Publicado: (2021)

High preoperative albumin-bilirubin score predicts poor survival in patients with newly diagnosed high-grade gliomas
por: Zhang, Jie, et al.
Publicado: (2021)

Integrating bulk and single-cell RNA sequencing data reveals epithelial-mesenchymal transition molecular subtype and signature to predict prognosis, immunotherapy efficacy, and drug candidates in low-grade gliomas
por: Wang, Chengcheng, et al.
Publicado: (2023)

Integrated analysis of inflammatory response subtype-related signature to predict clinical outcomes, immune status and drug targets in lower-grade glioma
por: Cao, Yudong, et al.
Publicado: (2022)

RE-IRRADIATION FOR RECURRENT HIGH-GRADE GLIOMA: AN ANALYSIS OF PROGNOSTIC FACTORS FOR SURVIVAL AND PREDICTORS OF RADIATION NECROSIS
por: Moore-Palhares, Daniel, et al.
Publicado: (2023)

MN1 overexpression with varying tumor grade is a promising predictor of survival of glioma patients
por: Saini, Masum, et al.
Publicado: (2020)

A radiomic signature as a non-invasive predictor of progression-free survival in patients with lower-grade gliomas
por: Liu, Xing, et al.
Publicado: (2018)

Related Markers for the Precision Diagnosis of Complex Appendicitis in Children
por: Zhou, Jialin, et al.
Publicado: (2022)

PROTACs: Walking through hematological malignancies
por: Bou Malhab, Lara J., et al.
Publicado: (2023)

Metronomic Four-Drug Regimen Has Anti-tumor Activity in Pediatric Low-Grade Glioma; The Results of a Phase II Clinical Trial
por: Verschuur, Arnauld, et al.
Publicado: (2018)

Intravoxel incoherent motion diffusion-weighted MR imaging of gliomas: efficacy in preoperative grading
por: Hu, Yu-Chuan, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_8d67d651vt0o1bv1s7i68q3njp